Search NLS News

The company has appointed Natalie Carfora as Head of Market Access of its US subsidiary, Immunovia, Inc. Natalie Carfora brings deep expertise to the reimbursement process from prior market access roles at Scipher Medicine and Myriad Genetics, states Immunovia. She will take up her position on May 23, 2022. “The hire of Natalie as Head […]

Immunicum has announced updated interim results from the ongoing ADVANCE II clinical trial evaluating the company’s lead development program DCP-001, a novel therapeutic option for acute myeloid leukemia (AML) maintenance therapy in patients with measurable residual disease (MRD). The analysis demonstrates the therapeutic potential of DCP-001 to control MRD based on the complete read-out of […]

New research from Karolinska Institutet shows that a booster shot of mRNA vaccine to individuals who have received two doses of inactivated vaccine offers the same level of protection against COVID-19 as three doses of mRNA vaccine. “Our results indicate that one booster shot of an mRNA vaccine, as a complement to the cheaper but […]

BC Platforms has secured a multi-year contract to work with three Finnish Hospital District owned Biobanks (Clinical Biobanks) on improving access to, and automated management of, phenotypic, genomic, and clinical data. The project underpins Finland’s ambition to be a leading country for Real-World Data (RWD) studies, supporting the global development of novel treatments and enhancing […]

The popular conference Nordic Life Science Days is back in-person this autumn, offering hot topics, inspiring presentations and discussions, and not least, opportunities for the Nordic life science community to finally meet, mingle, network, share ideas, create business synergies and initiate partnerships. “We are back in-person after a long break. The 2020 event was postponed […]

BioInvent International has announced its novel anti-FcyRIIB antibody BI-1206 is progressing into the expansion phase of a Phase 1/2a trial for non-Hodgkin’s lymphoma (NHL), following a positive End-of-Phase 1 meeting with the US FDA. The Phase 1 data presented so far (December 2021) include early signs of efficacy in the form of three long-lasting complete […]

Hansa Biopharma has announces that the Swiss Agency for Therapeutic Products (Swissmedic) has granted temporary marketing authorization for Idefirix in adult patients with a positive crossmatch against an available organ from a diseased donor. The use of Idefirix in Switzerland is reserved for patients with a low probability of being transplanted within the framework of […]

First local managing director for Shimadzu Denmark / Joachim Holm is a sales expert with experience in pharma, life science and medical products / Expertise bolstered at the office covering the Danish market. Joachim Holm is the first local managing director of the Shimadzu office in Denmark. On 1 April, he took over the reins […]

Testa Center has appointed a new CEO, Jesper Hedberg (PhD). Jesper Hedberg has been part of Testa Center since its inception and until now, has served as Director of Testa Center. He takes over from Lotta Ljungqvist. “I am looking forward to continuing the development of Testa Center and our work in bridging the gap […]

Targovax has entered into a clinical trial collaboration agreement with Oslo University Hospital (OUS) to run a phase 1/2 study testing polyvalent mutant RAS vaccine TG01 in multiple myeloma (MM) following standard of care (SoC) therapy. Targovax was recently awarded two research grants from Innovation Norway and the Norwegian Research Council, totaling NOK 18m, to […]